Literature DB >> 26728997

Regulation of soluble Flt-1 (VEGFR-1) production by hnRNP D and protein arginine methylation.

Takayuki Ikeda1, Yasuo Yoshitomi1, Hidehito Saito1, Takeo Shimasaki2, Hideki Yamaya3, Takashi Kobata4, Yasuhito Ishigaki2, Naohisa Tomosugi2, Yoshino Yoshitake1, Hideto Yonekura5.   

Abstract

Soluble fms-like tyrosine kinase-1 (sFlt-1) functions as a potent inhibitor of angiogenesis by trapping vascular endothelial growth factor (VEGF). However, the precise regulatory mechanism of sFlt-1 production is unknown. Here, we report that vascular sFlt-1 production is regulated by heterogeneous nuclear ribonucleoprotein D (hnRNP D) and arginine methylation. We showed that hnRNP D bound to Flt-1 pre-mRNA and that hnRNP D overexpression decreased sFlt-1 mRNA in human microvascular endothelial cells (HMVECs). In contrast, the reduction of hnRNP D levels induced an increase in sFlt-1 production. Overexpression of an hnRNP D mutant in which the arginine residue of the known arginine methylation motif (arginine-glycine-glycine; RGG) was replaced with alanine did not reduce the level of soluble-form RNA produced from the Flt-1 minigene. Moreover, we demonstrated that overexpression of arginine methyltransferase decreased the soluble-form RNA level, whereas overexpression of arginine demethylase and addition of methyltransferase inhibitors increased sFlt-1 mRNA levels. These findings indicate that hnRNP D and arginine methylation play important roles in the regulation of Flt-1 mRNA alternative polyadenylation.

Entities:  

Keywords:  Alternative polyadenylation; Arginine methylation; VEGF; hnRNP D; sFlt-1

Mesh:

Substances:

Year:  2016        PMID: 26728997     DOI: 10.1007/s11010-015-2649-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

Review 1.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

Authors:  A W Griffioen; G Molema
Journal:  Pharmacol Rev       Date:  2000-06       Impact factor: 25.468

Review 2.  Mechanisms and consequences of alternative polyadenylation.

Authors:  Dafne Campigli Di Giammartino; Kensei Nishida; James L Manley
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

Review 3.  Arginine methylation an emerging regulator of protein function.

Authors:  Mark T Bedford; Stéphane Richard
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

Review 4.  Defining the RGG/RG motif.

Authors:  Palaniraja Thandapani; Timothy R O'Connor; Timothy L Bailey; Stéphane Richard
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

5.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function.

Authors:  Jing Jin; Karen Sison; Chengjin Li; Ruijun Tian; Monika Wnuk; Hoon-Ki Sung; Marie Jeansson; Cunjie Zhang; Monika Tucholska; Nina Jones; Dontscho Kerjaschki; Masabumi Shibuya; I George Fantus; Andras Nagy; Hans-Peter Gerber; Napoleone Ferrara; Tony Pawson; Susan E Quaggin
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

Review 7.  Protein arginine methylation in mammals: who, what, and why.

Authors:  Mark T Bedford; Steven G Clarke
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

8.  Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.

Authors:  Ling Luo; Hironori Uehara; Xiaohui Zhang; Subrata K Das; Thomas Olsen; Derick Holt; Jacquelyn M Simonis; Kyle Jackman; Nirbhai Singh; Tadashi R Miya; Wei Huang; Faisal Ahmed; Ana Bastos-Carvalho; Yun Zheng Le; Christina Mamalis; Vince A Chiodo; William W Hauswirth; Judit Baffi; Pedro M Lacal; Angela Orecchia; Napoleone Ferrara; Guangping Gao; Kim Young-Hee; Yingbin Fu; Leah Owen; Romulo Albuquerque; Wolfgang Baehr; Kirk Thomas; Dean Y Li; Kakarla V Chalam; Masabumi Shibuya; Salvatore Grisanti; David J Wilson; Jayakrishna Ambati; Balamurali K Ambati
Journal:  Elife       Date:  2013-06-18       Impact factor: 8.140

9.  Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing.

Authors:  Takayuki Ikeda; Li Sun; Naoki Tsuruoka; Yasuhito Ishigaki; Yasuo Yoshitomi; Yoshino Yoshitake; Hideto Yonekura
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

10.  AUF1/hnRNP D represses expression of VEGF in macrophages.

Authors:  Abigail Fellows; Mary E Griffin; Brenda L Petrella; Lihui Zhong; Fatemeh P Parvin-Nejad; Roy Fava; Peter Morganelli; R Brooks Robey; Ralph C Nichols
Journal:  Mol Biol Cell       Date:  2012-02-29       Impact factor: 4.138

View more
  7 in total

1.  VEGF-A regulates sFlt-1 production in trophoblasts through both Flt-1 and KDR receptors.

Authors:  Zhonglin Xiao; Songjun Li; Yan Yu; Mengxia Li; Jie Chen; Feng Wang; Jian Zhang; Weifen Deng; Qing Yang; Xiujun Fan
Journal:  Mol Cell Biochem       Date:  2018-03-01       Impact factor: 3.396

2.  Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function.

Authors:  Veerle Kremer; Jetta J Oppelaar; Theresa Gimbel; Susanne Koziarek; Wessel Ganzevoort; Mariëlle G van Pampus; Bert-Jan van den Born; Liffert Vogt; Christianne de Groot; Reinier A Boon
Journal:  Reprod Sci       Date:  2022-08-04       Impact factor: 2.924

3.  FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia.

Authors:  Ami Ashar-Patel; Yasin Kaymaz; Augustine Rajakumar; Jeffrey A Bailey; S Ananth Karumanchi; Melissa J Moore
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

Review 4.  Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.

Authors:  Megan Stevens; Sebastian Oltean
Journal:  Cells       Date:  2019-03-28       Impact factor: 6.600

Review 5.  Alternative Splicing in Angiogenesis.

Authors:  Elizabeth Bowler; Sebastian Oltean
Journal:  Int J Mol Sci       Date:  2019-04-26       Impact factor: 5.923

Review 6.  Role of Arginine Methylation in Alternative Polyadenylation of VEGFR-1 (Flt-1) pre-mRNA.

Authors:  Takayuki Ikeda; Hidehito Saito-Takatsuji; Yasuo Yoshitomi; Hideto Yonekura
Journal:  Int J Mol Sci       Date:  2020-09-04       Impact factor: 5.923

7.  Protective Effects of Collagen Tripeptides in Human Aortic Endothelial Cells by Restoring ROS-Induced Transcriptional Repression.

Authors:  Hidehito Saito-Takatsuji; Yasuo Yoshitomi; Yasuhito Ishigaki; Shoko Yamamoto; Noriaki Numata; Yasuo Sakai; Masayoshi Takeuchi; Naohisa Tomosugi; Shogo Katsuda; Hideto Yonekura; Takayuki Ikeda
Journal:  Nutrients       Date:  2021-06-29       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.